Therapy of hyperlipoproteinemia type IIa, IIb and IV with Etofibrate retard
Schwartzkopff, W.; Schilling, A.; Calder, D.
Die Medizinische Welt 31(14): 515-520
1980
ISSN/ISBN: 0025-8512 PMID: 7374415 Document Number: 164564
Document emailed within 1 workday
Related Documents
Mertz, D.P.; Loewer, H.; Suermann, I. 1979: The range and lipid-lowering effect of etofibrate as a retard-preparation in patients with hyperlipoproteinemia type IIa Medizinische Klinik 74(51-52): 1953-1956Bartz, V.T.; Gatz, J.; Slotty, C.; Schröter, C.; Töle, R.; Wand, P. 1993: Long-term treatment of hyperlipoproteinemia with etofibrate Fortschritte der Medizin 111(25): 398-400
Kuŝić, M.; Gavrilović, M.; Mihajloviĉ, M.; Boŝković, B. 1980: Results of 6 months, therapy of familial hypercholesterolemia (hyperlipoproteinemia type II) with colestipol Srpski Arhiv Za Celokupno Lekarstvo 108(9): 875-881
Wessels, G. 1977: Hyperlipoproteinemia type V Fredrickson. a rare metabolic disorder, its diagnosis and therapy, as demonstrated on an own case Die Medizinische Welt 28(3): 136-137
Krüger, B. 1994: Etofibrate therapy and effect of added low-dose cholestyramine in patients with combined hyperlipidaemia International Journal of Clinical Pharmacology Research 14(5-6): 177-183
Bolzano, K.; Krempler, F.; Schellenberg, B.; Schlierf, G. 1979: A comparison of bezafibrate and clofibrate in type Ii B and type IV hyperlipoproteinemia Acta Medica Austriaca 6(3): 90-94
Arntz, H.R.; Klemens, U.H.; Vollmar, L.J.; Lang, P.D. 1978: Comparison of clofibrate and bezafibrate in type IIa and type IIb hyperlipoproteinemia Medizinische Klinik 73(49): 1731-1737
Lapka, R.; Pospísil, A.; Sedlmayer, P.; Rejholec, V.; Rezanka, V.; Smolík, S.; Franc, Z. 1985: Comparison of the biological availability of retard and non-retard lisuride tablets in dogs Ceskoslovenska Farmacie 34(1): 3-6
Heckers, H.; Oehler, G. 1975: Type-V-hyperlipoproteinemia Die Medizinische Welt 26(39): 1766-1774
Calderín, F.M.; Perianes, J.; Nuño, J.; De Oya, M. 1977: Hyperlipoproteinemia type i Revista Clinica Espanola 147(1): 81-84
Bustos, P.; Fernández, E.; Radrigán, E. 1987: Hyperlipoproteinemia type i Revista Chilena de Pediatria 58(6): 481-484
Matsuura, F. 2007: Familial hyperlipoproteinemia, type IV Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 7): 326-328
Morrone, G.; Franco, G.; Di Muccio, G.; Cappello, A. 1978: A case of type IV hyperlipoproteinemia La Pediatria 86(4): 667-677
Di Gruttola, G.; Ferrara, M. 1977: Familial congenital type IIB hyperlipoproteinemia La Pediatria 85(3): 435-442
Schoenborn, W.; Fuhrmann, W.; Huth, K. 1973: Hyperlipoproteinemia type 3 in kidney diseases Verhandlungen der Deutschen Gesellschaft für Innere Medizin 79: 1280-1283
Andersen, G.E.; Friis-Hansen, B. 1976: Neonatal diagnosis of familial type Ii hyperlipoproteinemia Pediatrics 57(2): 214-220
Mertz, D.P.; Suermann, I.; Göhmann, E. 1978: Clofibrate in type IIa hyperlipoproteinemia. Reduction of apolipoprotein B Münchener Medizinische Wochenschrift 120(34): 1097-1099
Hagve, T.A.; Furuset, T.; Christophersen, B.; Ose, L. 1993: Apolipoprotein e phenotyping--useful in the study of hyperlipoproteinemia type IIi Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 113(7): 853-856
Masket, B.H.; Levy, R.I.; Fredrickson, D.S. 1973: The use of polyacrylamide gel electrophoresis in differentiating type 3 hyperlipoproteinemia Journal of Laboratory and Clinical Medicine 81(5): 794-802
Hsia, S.H.; Connelly, P.W.; Hegele, R.A. 1995: Restriction isotyping of apolipoprotein E R145C in type III hyperlipoproteinemia Journal of Investigative Medicine: the Official Publication of the American Federation for Clinical Research 43(2): 187-194